Truman Hunt - Nu Skin CEO and President and Director

NUS
 Stock
  

USD 44.72  1.42  3.28%   

  CEO
Mr. M. Truman Hunt is no longer Vice Chairman of the Board of the Company., effective June 30, 2017. He also joined our board of directors when he was named Chief Executive Officer. Mr. Hunt has served in various positions with our company since 1994, including Executive Vice President from 2001 to 2003 and General Counsel from 1996 to 2003. From 2005 until 2008, Mr. Hunt served as chairman of the World Federation of Direct Selling Associations, a global trade association for the direct selling industry
Age: 56        
801 345-1000  www.nuskin.com
Hunt also served as chairman of the board of directors for the United States Direct Selling Association from 2014 to 2015. He received a B.S. degree from Brigham Young University and a J.D. degree from the University of Utah.

Nu Skin Management Efficiency

Nu Skin Enterprises has Return on Asset of 9.46 % which means that on every $100 spent on asset, it made $9.46 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 16.3 %, implying that it generated $16.3 on every 100 dollars invested. Nu Skin management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/01/2022, Return on Investment is likely to grow to 30.63. Also, Return on Average Assets is likely to grow to 13.76. Nu Skin Revenue to Assets are relatively stable at the moment as compared to the past year. Nu Skin reported last year Revenue to Assets of 1.52. As of 07/01/2022, Net Current Assets as percentage of Total Assets is likely to grow to 24.00, while Current Assets are likely to drop slightly above 739.6 M.
The company has 503.78 M in debt with debt to equity (D/E) ratio of 0.55, which is OK given its current industry classification. Nu Skin Enterprises has a current ratio of 1.62, which is typical for the industry and considered as normal. Debt can assist Nu Skin until it has trouble settling it off, either with new capital or with free cash flow. So, Nu Skin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nu Skin Enterprises sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nu Skin to invest in growth at high rates of return. When we think about Nu Skin's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 14 records

CEO Since

Martin RiantProcter Gamble
N/A
Barbara RentlerRoss Stores
2014
Ma FranciscoProcter Gamble
2018
Timothy WilmottPenn Natl Gaming
2017
Andre CalantzopoulosPhilip Morris International
2021
Martin KingPhilip Morris International
2020
Michael BaurScansource
2019
Shailesh JejurikarProcter Gamble
2021
Fama FranciscoProcter Gamble
2018
Jacek OlczakPhilip Morris International
2021
Denise PaulonisSally Beauty Holdings
2021
Christian BrickmanSally Beauty Holdings
2015
John DonahoeNike Inc
2020
Mark ParkerNike Inc
2020
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. Nu Skin operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 4600 people. Nu Skin Enterprises (NUS) is traded on New York Stock Exchange in USA and employs 4,600 people.

Nu Skin Enterprises Leadership Team

Elected by the shareholders, the Nu Skin's board of directors comprises two types of representatives: Nu Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nu Skin. The board's role is to monitor Nu Skin's management team and ensure that shareholders' interests are well served. Nu Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nu Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nevin Andersen, Independent Director
Scott Pond, Director - Investor Relations
Mark Lawrence, Chief Financial Officer, Executive Vice President
D Dorny, Executive Vice President, General Counsel, Secretary
Ritch Wood, CFO, Principal Accounting Officer and VP
Daniel Campbell, Lead Independent Director
Edwina Woodbury, Independent Director
Zhequing Shen, Director
Chayce Clark, Executive Vice President General Counsel
Joseph Chang, Executive Vice President - Product Development, Chief Scientific Officer
Truman Hunt, CEO and President and Director
Laura Nathanson, Independent Director
Steven Lund, Executive Chairman of the Board
Matthew Dorny, VP, General Counsel and Secretary
Emma Battle, Director
Connie Tang, Executive Vice President Chief Global Growth & customer Experience Officer
Thomas Pisano, Independent Director
Neil Offen, Independent Director
Scott Schwerdt, President - Americas Region
Zheqing Shen, Independent Director
Andrew Lipman, Independent Director
James Thomas, Chief Accounting Officer
Ryan Napierski, President, Chief Executive Officer, Director

Nu Skin Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nu Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Nu Skin without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nu Skin Enterprises using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Nu Skin Enterprises information on this page should be used as a complementary analysis to other Nu Skin's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Nu Skin Stock analysis

When running Nu Skin Enterprises price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know Nu Skin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.16
Market Capitalization
2.2 B
Quarterly Revenue Growth YOY
-0.11
Return On Assets
0.0916
Return On Equity
0.15
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of Nu Skin that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine Nu Skin value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.